leisure time -WSS

leisure time

author：entertainment 2025-09-03 03:44:01 - browse：576

A woman uses her phone to scan a barcode. -- Health coverage from STAT — A Color Health service promises to make it easier to get cancer screenings. Color Health

Color Health wants to take away any reason you might have for skipping screenings for cancer.

The Silicon Valley company, which pivoted from cancer genomics to Covid-19 testing on a large and hugely profitable scale, has a new program that incorporates both its roots in cancer testing and its logistical experience from the pandemic. Called, simply, the Cancer Prevention and Screening Program, and built in partnership with the American Cancer Society, the program aims to make it easy to get the appropriate screenings, whether at a clinic or at home.

“If we can take away all your excuses for not doing the prevention, can we get you to do the prevention,” said Alicia Zhou, the company’s chief scientific officer. “It’s bringing the care to the patient, instead of bringing the patient to care.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： How to protect patients from sexual assault

hotspot

WSS

How AI can help patients find reliable information about doctors

STAT Summit: Ending the crisis of Black deaths in the U.S.

Study on Amgen’s bispecific immunotherapy produces positive data

Stem cell treatment guidelines are released by FDA

Ethical issues complicate the benefits of medical crowdfunding

NIH nominee Bertagnolli will get October confirmation hearing

explore

leisure time

focus

Activists slam private health insurers over coverage restrictions

Readout Newsletter: AstraZeneca's CEO, Roivant's $5 billion deal

The high cost of giving birth even with insurance

Trump surgeon general acknowledges mistakes during Covid

Peter Hotez and the public health issue of online harassment

Why a market frenzy over new weight loss drugs defies logic

Heart attack and stroke risk calculators need revising

ADCs take center stage as promising cancer treatments

As demand for Covid shots wanes, Moderna seeks its next success

STAT Readout Newsletter: Biotech news today

explore

What American doctors can learn from their Israeli counterparts

Stem cell treatment guidelines are released by FDA

Weighted lottery helped low

Biotech execs pursue obesity drug boom: ‘It’s the early innings’

STAT Summit: The economic case for universal basic health care

STAT Summit: Doctor v. ChatGPT showed AI's promise, blind spots

knowledge

leisure time

hotspot

focus